MC2 Therapeutics chose a partner in China that can lift more than its main asset Wynzora
A partnership between Danish biotech company MC2 Therapeutics and Chinese pharmaceutical company Huadong Pharmaceutical announced on Thursday, has the potential to grow in scope in the coming years.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.